LAS41005

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAS41005, covering 2015-05-29 to 2015-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis [Phase 3]